Is Wall Street Bullish or Bearish on AbbVie Stock?

Valued at a market cap of $336 billion, AbbVie Inc. (ABBV) is a global biopharmaceutical company dedicated to developing innovative therapies that address complex health challenges. Headquartered in North Chicago, Illinois, AbbVie focuses on research-driven solutions in immunology, oncology, neuroscience, and other critical areas, improving the lives of millions of patients worldwide.

Shares of the pharma company have underperformed the broader market over the past 52 weeks. ABBV has surged 12.6% over this time frame, while the broader S&P 500 Index ($SPX) has climbed 21.8%. However, in 2025, shares of AbbVie are up 6.9%, surging past SPX’s 2.7% rise on a YTD basis.